Ishita Drugs & Industries Ltd. Share Price & Stock Analysis

Ishita Drugs & Industries Ltd. (BSE: 524400) is an Ahmedabad, Gujarat-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹22 Cr, it ranks #4,374 by market cap among the 6,197 Indian listed companies on FinBizNet, and #77 of 86 in Medicinal Chemicals and Botanical Products. At ₹72.76 (as of 16 Nov 2026), the share price is 19.9% below its 52-week high of ₹90.85 and 10.2% above its 52-week low of ₹66.00. The share price is up 1.6% over one year and up 2.2% over three months.

Key Metrics

Current Price₹72.76
Market Cap₹22 Cr
BSE Code524400
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E Ratio28
Return on Equity6.96%
Return on Assets3.03%
52-Week Range₹66.00 – ₹90.85
1-Year Price Change+1.6%
3-Month Price Change+2.2%
Beta (1Y)-0.05
HeadquartersAhmedabad, Gujarat
Websitewww.ishitadrugs.com

Shareholding and Delivery

Delivery averaged 92.9% of traded volume across 14 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Ishita Drugs & Industries Ltd.

Ishita Drugs and Industries Limited manufactures and sells active pharma ingredients (APIs), fine chemicals, drug intermediates, and excipients in India and internationally. The company offers APIs, such as sulfa drugs/sulfonamides, vitamins, fluoro quinolones, antibiotics, anthelmintics, iodides and citrates, food additives/excipients, and others. It also provides contract manufacturing services for various drug intermediates, fine chemicals, or specialty chemicals. Ishita Drugs and Industries Limited was incorporated in 1992 and is based in Ahmedabad, India.

Products and Services

1. Pharmaceutical Business-This segment manufactures and markets various active pharma ingredients, drug intermediates, excipients, finished dosage forms, and fine chemicals.

Business Segments

1. Pharmaceutical Business-100%

Ishita Drugs & Industries Ltd. vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Ishita Drugs & Industries Ltd.₹22 Cr286.96%—+1.6%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Ishita Drugs & Industries Ltd.?

Ishita Drugs & Industries Ltd. is trading at ₹72.76, with a market capitalisation of ₹22 Cr.

Which sector does Ishita Drugs & Industries Ltd. belong to?

Ishita Drugs & Industries Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Ishita Drugs & Industries Ltd.?

Ishita Drugs & Industries Ltd. has a P/E of 28 and a return on equity of 6.96%.

What is the stock symbol of Ishita Drugs & Industries Ltd.?

Ishita Drugs & Industries Ltd. is listed on the BSE under the scrip code 524400.

How has Ishita Drugs & Industries Ltd.'s share price moved over the past year?

Ishita Drugs & Industries Ltd.'s share price is up 1.6% over one year and up 2.2% over three months. Its 52-week range is ₹66.00 to ₹90.85.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.